{"entity":{"type":"insider","cik":"0001397331","url":"/insider/0001397331","json_url":"/insider/0001397331.json","name":"Williamson Robert F III","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":11,"first":"2011-05-10","last":"2025-11-14","span_basis":"filed_date"},"name_variants":[{"name":"Williamson Robert F III","source":"filing","n_filings":11,"first_seen":"2011-05-10","last_seen":"2025-11-14"}],"transactions":[{"id":4880012,"accession":"0001193125-25-281626","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-281626","line_url":"/filing/0001193125-25-281626#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9498.0,"shares_display":"9,498","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":19945.8,"total_display":"19,945.80","total_whole":"19,946","shares_owned_after":9864.0,"shares_owned_after_display":"9,864","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4660747,"accession":"0000950170-25-048698","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-048698","line_url":"/filing/0000950170-25-048698#line-2","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38145.0,"shares_display":"38,145","price_per_share":2.1438,"price_display":"2.14","price_state":"stated","total_value":81775.251,"total_display":"81,775.25","total_whole":"81,775","shares_owned_after":108982.0,"shares_owned_after_display":"108,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-31","filed_date":"2025-04-01","scope":"insider"},{"id":4660743,"accession":"0000950170-25-048698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-048698","line_url":"/filing/0000950170-25-048698#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22192.0,"shares_display":"22,192","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":50375.84,"total_display":"50,375.84","total_whole":"50,376","shares_owned_after":70837.0,"shares_owned_after_display":"70,837","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-28","filed_date":"2025-04-01","scope":"insider"},{"id":3152998,"accession":"0000950170-24-131251","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-131251","line_url":"/filing/0000950170-24-131251","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6266.0,"shares_display":"6,266","price_per_share":3.6408402968400893,"price_display":"3.64","price_state":"stated","total_value":22813.5053,"total_display":"22,813.51","total_whole":"22,814","shares_owned_after":427439.0,"shares_owned_after_display":"427,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider","n_lines":2},{"id":3254605,"accession":"0000950170-24-067945","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-067945","line_url":"/filing/0000950170-24-067945#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55000.0,"shares_display":"55,000","price_per_share":1.38,"price_display":"1.38","price_state":"stated","total_value":75900.0,"total_display":"75,900.00","total_whole":"75,900","shares_owned_after":423792.0,"shares_owned_after_display":"423,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-03","scope":"insider"},{"id":2950239,"accession":"0000950170-24-066557","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-066557","line_url":"/filing/0000950170-24-066557","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30031.0,"shares_display":"30,031","price_per_share":1.3324244946888215,"price_display":"1.33","price_state":"stated","total_value":40014.04,"total_display":"40,014.04","total_whole":"40,014","shares_owned_after":368792.0,"shares_owned_after_display":"368,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-30","scope":"insider","n_lines":2},{"id":3088015,"accession":"0001437749-24-002837","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001437749-24-002837","line_url":"/filing/0001437749-24-002837","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":127206.0,"shares_display":"127,206","price_per_share":0.713095687310347,"price_display":"0.71","price_state":"stated","total_value":90710.05,"total_display":"90,710.05","total_whole":"90,710","shares_owned_after":292382.0,"shares_owned_after_display":"292,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-02-01","scope":"insider","n_lines":5},{"id":2371623,"accession":"0001437749-24-002571","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001437749-24-002571","line_url":"/filing/0001437749-24-002571","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25266.0,"shares_display":"25,266","price_per_share":0.64,"price_display":"0.64","price_state":"stated","total_value":16170.24,"total_display":"16,170.24","total_whole":"16,170","shares_owned_after":211555.0,"shares_owned_after_display":"211,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-29","filed_date":"2024-01-30","scope":"insider","n_lines":2},{"id":2371621,"accession":"0001437749-24-002571","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001437749-24-002571","line_url":"/filing/0001437749-24-002571","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":110613.0,"shares_display":"110,613","price_per_share":0.5632581161346315,"price_display":"0.56","price_state":"stated","total_value":62303.67,"total_display":"62,303.67","total_whole":"62,304","shares_owned_after":186289.0,"shares_owned_after_display":"186,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-30","scope":"insider","n_lines":5},{"id":2901248,"accession":"0001437749-24-002322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-24-002322","line_url":"/filing/0001437749-24-002322#line-2","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22134.0,"shares_display":"22,134","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":10845.66,"total_display":"10,845.66","total_whole":"10,846","shares_owned_after":75676.0,"shares_owned_after_display":"75,676","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-25","filed_date":"2024-01-26","scope":"insider"},{"id":2901243,"accession":"0001437749-24-002322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-002322","line_url":"/filing/0001437749-24-002322#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29862.0,"shares_display":"29,862","price_per_share":0.49,"price_display":"0.49","price_state":"stated","total_value":14632.38,"total_display":"14,632.38","total_whole":"14,632","shares_owned_after":53542.0,"shares_owned_after_display":"53,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-24","filed_date":"2024-01-26","scope":"insider"},{"id":8366471,"accession":"0001437749-23-035321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-035321","line_url":"/filing/0001437749-23-035321#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3663.0,"shares_display":"3,663","price_per_share":0.3283,"price_display":"0.33","price_state":"stated","total_value":1202.5629,"total_display":"1,202.56","total_whole":"1,203","shares_owned_after":3663.0,"shares_owned_after_display":"3,663","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-12-21","filed_date":"2023-12-26","scope":"insider"},{"id":8711767,"accession":"0001437749-23-034933","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-23-034933","line_url":"/filing/0001437749-23-034933#line-2","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13680.0,"shares_display":"13,680","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":4377.6,"total_display":"4,377.60","total_whole":"4,378","shares_owned_after":23680.0,"shares_owned_after_display":"23,680","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-19","filed_date":"2023-12-19","scope":"insider"},{"id":8711765,"accession":"0001437749-23-034933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-034933","line_url":"/filing/0001437749-23-034933#line-1","is_derivative":false,"issuer_cik":"0000728387","issuer_name":"Perspective Therapeutics, Inc.","issuer_ticker":"CATX","issuer_name_source":null,"issuer_url":"/issuer/0000728387","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":2600.0,"total_display":"2,600.00","total_whole":"2,600","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-18","filed_date":"2023-12-19","scope":"insider"},{"id":9006847,"accession":"0001192482-11-000120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001192482-11-000120","line_url":"/filing/0001192482-11-000120#line-2","is_derivative":false,"issuer_cik":"0001301081","issuer_name":"Pharmasset Inc","issuer_ticker":"VRUS","issuer_name_source":null,"issuer_url":"/issuer/0001301081","owner_cik":"0001397331","owner_name":"Williamson Robert F III","owner_display_name":"Williamson Robert F III","owner_url":"/insider/0001397331","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31666.0,"shares_display":"31,666","price_per_share":104.3582,"price_display":"104.36","price_state":"stated","total_value":3304606.7612,"total_display":"3,304,606.76","total_whole":"3,304,607","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-06","filed_date":"2011-05-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":25,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000728387","name":"Perspective Therapeutics, Inc.","url":"/issuer/0000728387","role":"Director","n_filings":10,"first_seen":"2023-12-19","last_seen":"2025-11-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001301081","name":"Pharmasset Inc","url":"/issuer/0001301081","role":"Director","n_filings":1,"first_seen":"2011-05-10","last_seen":"2011-05-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001397331","retrieved_at":"2026-08-24T18:20:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}